Followers | 37 |
Posts | 4190 |
Boards Moderated | 0 |
Alias Born | 10/18/2016 |
Monday, March 13, 2017 9:04:57 AM
Substance abuse and addiction remain a serious problem across the United States, generating more than $700 billion a year in expenses related to health care, crime, work productivity and more, according to the National Institute on Drug Abuse (http://nnw.fm/9IpUl). Abuse of tobacco, illicit drugs and alcohol remains high, along with the number of prescription drug users nationwide. Unfortunately, not all people suffering from a substance abuse problem get the treatment they need, or perhaps access to any kind of treatment at all, with potentially lethal consequences. GreeneStone Healthcare Corp. (OTCQB: GRST), a Canadian-founded provider of healthcare services, with a focus on addiction and mental health, is hoping to change this as it enters the U.S. market with a unique and tested approach to the substance abuse recovery process.
The company recently sold its Canadian addiction business and is planning to open a new treatment center in Florida after acquiring the real estate assets and business of Delray Beach-based Seastone addiction center. Known as a leading and first addiction treatment of the kind in Canada, GreeneStone has used modern philosophies and techniques to successfully treat hundreds of patients, and it has been planning to expand its operations to the U.S. as well. The first step is the Florida clinic, where the company hopes to use the skills acquired in Canada to revolutionize addiction treatment.
According to the Addiction Blog (http://nnw.fm/IFs1A), Florida has a severe substance problem and one of the highest overdose mortality rates in the United States. With more than 300 illegal methamphetamine labs seized and almost 3,000 drug induced deaths per year, the need for comprehensive and effective substance abuse and addiction treatment is evident. In addition, Florida also prescribes up to 10 times more oxycodone pills than all the other states combined, which in turn causes a major increase in the number of addiction patients throughout the state.
GreeneStone’s unique approach to substance abuse recovery is based on the best practices and principles available and focuses on treating not only the addiction problem but also any co-occurring and underlying disorders that enabled the addiction behavior in the first place. GreeneStone applies unique assessment tools to evaluate the extent and nature of the brain disorders in its clients so that it may effectively tailor the treatment plan. With a non-judgmental, client-centered approach that respects the need for privacy, independence and autonomy and embraces diversity, GreeneStone is developing personalized, holistic treatments for its patients, based on their individual beliefs and situation.
Additionally, all treatments are results oriented and based on the idea of inclusion – meaning that each client benefits from core team support consisting of friends or family. Counseling and education are also provided to family members and friends who are part of patients’ support teams, with the goal of helping them get a better understanding of what their loved ones are going through, what addiction entails and how they can help during and after the recovery process.
For more information, visit the company’s website at www.GreeneStone.net
Recent GRST News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 08:46:15 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 07:23:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/29/2024 05:40:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/29/2024 05:39:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 09:25:38 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 06/11/2024 06:20:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 02:47:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/31/2024 08:27:28 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/07/2024 08:16:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:45:09 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:04:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:55:26 PM
- Form 1-A POS - • Edgar (US Regulatory) • 10/20/2023 07:29:40 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM